由于药物短缺,在败血栓冲击管理中用于血液动力学支持的皮替代品
Mohammed Aldhaeefi1, Abdulrahman Alshaya2,3,4, Sanaa Belrhiti5
1Department of Clinical and Administrative Pharmacy Sciences, College of Pharmacy, Howard University, Washington, DC, USA.
Critical care explorations
|June 28, 2023
概括
败血症和败血性休克需要及时治疗. 由于水皮质缺乏,临床医生可以考虑甲基prednisolone或甲作为耐火性败血性休克患者的替代品.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 败血症是一种危及生命的疾病,其特点是由于宿主对感染的反应失调而导致器官功能障碍.
- 败血性休克是一种严重的败血症形式,在这种情况下,液体复苏无法维持足够的血压.
- 目前的指导方针建议在耐火性败血症休克时使用皮质类固醇,强调了药物可用性的重要性.
研究的目的:
- 为了解决目前静脉注射皮的短缺问题.
- 为指导临床医生选择适合的替代性皮质类固醇用于感染性休克管理.
- 为了确保耐火性败血症休克患者的护理连续性.
主要方法:
- 审查当前的生存败血症运动指南.
- 识别可用的治疗替代品,以皮.
- 对药物短缺潜在病因的分析.
主要成果:
- 监管机构和专业机构已经宣布静脉注射皮的短缺.
- 甲基prednisolone和德克萨米他被确定为可行的治疗替代品.
- 了解药物短缺的原因对于主动管理至关重要.
结论:
- 临床医生应准备好使用替代性皮质类固醇,如甲基普雷迪尼索隆或德克萨米他在水皮质不可用的情况下.
- 感染性休克的有效管理取决于必需药物的可获得性.
- 需要采取积极的战略,以减轻重症监护机构药物短缺的影响.
相关概念视频
Blood Pressure Imbalances and Circulatory Shock
819
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
819
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Heart Failure V: Medical Management
15
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
15
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
467
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
467
Adrenergic Agonists: Therapeutic Uses
858
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
858
Cardiopulmonary Resuscitation IV: Pharmacological Management
29
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
29


